Strand Health Inc. – Trademark Portfolio
Entity Type: 03
Strand Health Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include EVERFUR. The owner is based in Brooklyn, NY.
595 Dean Street
Apt. 2238
Brooklyn, NY 11238
Showing of trademarks Trademarks
Trademark Classifications
Strand Health Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Strand Health Inc. have?
Strand Health Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.
What trademark classes does Strand Health Inc. file in?
Strand Health Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Strand Health Inc.'s most well-known trademarks?
Strand Health Inc.'s registered trademark portfolio includes well-known marks such as EVERFUR. These are among 1 currently registered trademark in the portfolio.
What is Strand Health Inc.'s trademark registration success rate?
Strand Health Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.